RB
Robert Bruce (Bruce & Co) disclosed reduced in Abbvie
Robert Bruce (Bruce & Co) filed a 13F change in Abbvie (00287Y109) on 2025-08-14, covering period end 2025-06-30.
Action
Reduced
Capital
$23,666,550 current disclosed value
Institutional 13F Signals1 evidence source
Why it matters
This signal is selected by portfolio impact within the manager filing, while the full filing change list remains available in the briefing.
Full Filing Changes
43 changes from Robert Bruce (Bruce & Co), filed 2025-08-14 for period end 2025-06-30.
$308.5M portfolio value
| Stock | Action | Change | Current | Portfolio Impact |
|---|---|---|---|---|
45774W108 Insteel | Increased | $3.7M | $12.8M | 1.21% |
125896100 CMS Energy | Reduced | -$3.4M | $13.6M | 1.10% |
00287Y109 Abbvie | Reduced | -$3.0M | $23.7M | 0.99% |
589331107 Merck | Reduced | -$2.9M | $15.3M | 0.95% |
N00985106 AerCap Holdings | Increased | $2.7M | $21.5M | 0.88% |
N53745100 Lyondellbasell | New | $2.3M | $2.3M | 0.75% |
23586506 Uhaul B | Reduced | -$2.2M | $24.6M | 0.70% |
651639106 Newmont | Increased | $998,000 | $5.8M | 0.32% |
925815102 Vicor | Increased | $807,800 | $4.1M | 0.26% |
05379B107 Avista | Reduced | -$789,880 | $7.6M | 0.26% |
71535D106 Personalis | Increased | $771,650 | $1.7M | 0.25% |
20002101 Allstate | Reduced | -$722,880 | $25.3M | 0.23% |
26441C204 Duke Energy | Reduced | -$697,990 | $20.7M | 0.23% |
37833100 Apple | Reduced | -$659,744 | $8.0M | 0.21% |
00430HAC6 Accelerate Diagnostic | Reduced | -$658,514 | $658,515 | 0.21% |
237266101 Darling Ingredients | Increased | $565,300 | $5.0M | 0.18% |
92333F101 Venture Global | Increased | $528,000 | $1.6M | 0.17% |
98389B100 XCEL Energy | Reduced | -$523,205 | $13.2M | 0.17% |
39483102 Archer Daniels | Increased | $477,000 | $5.3M | 0.15% |
68622V106 Organon | Sold out | -$464,568 | $0 | 0.15% |
302571104 Nextera Energy | Reduced | -$463,050 | $21.9M | 0.15% |
2824100 Abbott | Increased | $449,568 | $18.2M | 0.15% |
00206R102 AT & T | Increased | $444,180 | $19.5M | 0.14% |
23586100 Uhaul | Reduced | -$354,720 | $4.5M | 0.11% |
749607107 RLI | Reduced | -$330,888 | $2.9M | 0.11% |
H11356104 Bunge | Increased | $308,800 | $6.4M | 0.10% |
717081103 Pfizer | Reduced | -$299,090 | $6.6M | 0.10% |
50015M109 Kodiak Sciences | Increased | $297,160 | $1.2M | 0.10% |
56400P706 Mannkind | Reduced | -$251,644 | $729,573 | 0.08% |
65443P102 908 Devices | Increased | $180,958 | $486,879 | 0.06% |
268311107 EDAP | Reduced | -$177,169 | $907,989 | 0.06% |
163851108 Chemours | Increased | $156,500 | $2.9M | 0.05% |
44209104 Ashland | Reduced | -$135,150 | $754,200 | 0.04% |
449585108 IGM Bioscience | Sold out | -$115,000 | $0 | 0.04% |
868459108 Supernus | Reduced | -$100,989 | $2.6M | 0.03% |
532457108 Eli Lilly | Reduced | -$92,760 | $1.6M | 0.03% |
142038108 Caribou Biosciences | Increased | $87,500 | $315,000 | 0.03% |
31189P102 Fate Theraputics | Increased | $46,191 | $480,691 | 0.01% |
92939U106 WEC Energy | Increased | $40,081 | $411,069 | 0.01% |
91911K102 Bausch Health | Increased | $32,490 | $1.1M | 0.01% |
N51517105 Lava Theraputics | Increased | $26,094 | $688,874 | 0.01% |
82968B103 XM Sirius | Increased | $23,987 | $1.3M | 0.01% |
92556V106 Viatris | Increased | $12,821 | $520,431 | 0.00% |